Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk, Hallera 107, 80-416 Gdansk, Poland.
Department of Process Engineering and Chemical Technology, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233 Gdansk, Poland.
Biosensors (Basel). 2024 Jul 22;14(7):356. doi: 10.3390/bios14070356.
The steady progress in consumer electronics, together with improvement in microflow techniques, nanotechnology, and data processing, has led to implementation of cost-effective, user-friendly portable devices, which play the role of not only gadgets but also diagnostic tools. Moreover, numerous smart devices monitor patients' health, and some of them are applied in point-of-care (PoC) tests as a reliable source of evaluation of a patient's condition. Current diagnostic practices are still based on laboratory tests, preceded by the collection of biological samples, which are then tested in clinical conditions by trained personnel with specialistic equipment. In practice, collecting passive/active physiological and behavioral data from patients in real time and feeding them to artificial intelligence (AI) models can significantly improve the decision process regarding diagnosis and treatment procedures via the omission of conventional sampling and diagnostic procedures while also excluding the role of pathologists. A combination of conventional and novel methods of digital and traditional biomarker detection with portable, autonomous, and miniaturized devices can revolutionize medical diagnostics in the coming years. This article focuses on a comparison of traditional clinical practices with modern diagnostic techniques based on AI and machine learning (ML). The presented technologies will bypass laboratories and start being commercialized, which should lead to improvement or substitution of current diagnostic tools. Their application in PoC settings or as a consumer technology accessible to every patient appears to be a real possibility. Research in this field is expected to intensify in the coming years. Technological advancements in sensors and biosensors are anticipated to enable the continuous real-time analysis of various omics fields, fostering early disease detection and intervention strategies. The integration of AI with digital health platforms would enable predictive analysis and personalized healthcare, emphasizing the importance of interdisciplinary collaboration in related scientific fields.
消费电子产品的稳步发展,加上微流技术、纳米技术和数据处理的改进,已经实现了具有成本效益、用户友好的便携式设备,这些设备不仅是小工具,而且还是诊断工具。此外,许多智能设备监测患者的健康,其中一些被应用于即时护理 (PoC) 测试,作为评估患者病情的可靠来源。目前的诊断实践仍然基于实验室测试,首先采集生物样本,然后由经过专门培训的人员在临床条件下使用特殊设备对其进行测试。实际上,通过省略常规采样和诊断程序,同时排除病理学家的作用,从患者实时采集被动/主动生理和行为数据并将其输入人工智能 (AI) 模型,可以显著改善诊断和治疗程序的决策过程。结合传统和新型数字和传统生物标志物检测方法以及便携式、自主和微型化设备,可以在未来几年彻底改变医疗诊断。本文重点比较了基于 AI 和机器学习 (ML) 的传统临床实践与现代诊断技术。所提出的技术将绕过实验室并开始商业化,这应该会改进或替代当前的诊断工具。它们在即时护理环境中的应用或作为每个患者都可获得的消费者技术似乎是一种现实可能性。预计未来几年该领域的研究将加强。传感器和生物传感器的技术进步有望实现各种组学领域的连续实时分析,促进早期疾病检测和干预策略。将 AI 与数字健康平台集成将能够进行预测分析和个性化医疗,强调在相关科学领域进行跨学科合作的重要性。